Bioject Medical (BJCT) Inactive 10-K2007 FY Annual report

Filed: 28 Mar 08, 12:00am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. freshman Avg

New words: added, adding, addressed, advertising, affixed, arose, arrangement, arrearage, attestation, auto, barring, bore, breakeven, campaign, canine, Choice, CMDR, CompanyIn, concurrent, consummate, covenant, Cuba, culminating, David, deadline, description, disable, doctor, Dominican, extraordinary, feel, flexibility, forbear, forbearance, foreclose, foreclosing, Gerald, greatest, HealthIn, hired, hiring, hundred, Iject®are, Inactivated, inducement, inInternal, insufficient, launch, Makar, melanoma, MerialIn, multiplying, noncontrolling, Oman, open, opening, orpari, paragraph, partnership, PIK, pipeline, pledge, Polio, preferencepari, promising, promissory, Ralph, ratably, Reach, realignment, release, reliance, remeasurement, repriced, Republic, residual, revaluation, reverse, SeronoIn, Shipping, Signet, singular, situation, solicitation, sought, sparing, specialty, split, Sponsoring, strong, subordinated, swine, Tierney, Topic, Treadway, Tyco, UL, uncertain, undertaken, underwritten, unwilling, view, Vitajet®for, waiver

Removed: affiliate, Alaska, American, Anne, annualized, Arundel, asserted, assist, asterisk, attain, BB, Bureau, Cancer, certificate, chronology, compensatory, Confidential, configuration, Connector, constant, County, Defense, Department, disposition, diversifying, duly, duration, earned, easier, Elan, employ, eventually, exhibit, expose, finalized, fit, formed, Francisco, Frederick, freight, Geneva, glucose, headquartered, herewith, Hoffman, identify, index, Industrial, inflation, insolvency, interface, Japanese, joint, Kit, KPMG, La, level, leverage, LLP, manager, Marathon, matching, mature, maximize, MD, Medivax, Memorial, military, mitigate, mix, monitoring, move, mutual, nurse, painful, pediatric, portfolio, predict, profile, read, refill, remained, renewable, retail, ruedy, SAIC, San, Schedule, scheduled, Scientific, subcontract, Switzerland, targeted, thereto, thereunto, Trust, unaudited, undersigned, user, variability, venture, worldwide

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Related press release

BJCT similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

EXHIBIT 32.2

CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER

PURSUANT TO RULE 13a-14(b) OR RULE 15d-14(b)

OF THE SECURITIES EXCHANGE ACT OF 1934 AND 18 U.S.C. SECTION 1350

In connection with the Annual Report of Bioject Medical Technologies Inc. (the “Company”) on Form 10-K for the period ended December 31, 2007 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Christine M. Farrell, Principal Financial Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge,:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

/s/ Christine M. Farrell

Christine M. Farrell

Vice President of Finance and Principal Financial Officer

Bioject Medical Technologies Inc.

March 28, 2008

This certification is made solely for the purpose of 18 U.S.C. Section 1350, and not for any other purpose. A signed original of this written statement required by Section 906 has been provided to Bioject Medical Technologies Inc. and will be retained by Bioject Medical Technologies Inc. and furnished to the Securities and Exchange Commission or its staff upon request.